Evidence map›Paper›PMID 19629244›Full record

ArticleDeutsches Arzteblatt international2008

Epilepsy in childhood and adolescence.

Bernd A Neubauer, Stephanie Gross, Andreas Hahn

Abstract read
In one paragraph

Article in Deutsches Arzteblatt international, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Does angiogenesis play a role in the establishment of mesial temporal lobe epilepsy?International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience · 2016
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bernd A NeubauerAbteilung Neuropädiatrie, Sozialpädiatrie und Epileptologie, Zentrum Kinder- und Jugendmedizin, Universitätsklinikum Giessen und Marburg GmbH, Feulgenstrasse 12, Giessen, Germany. Bernd.A.Neubauer@paediat.med.uni-giessen.de
Stephanie Gross
Andreas Hahn

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMore than 3% of the total population will suffer from epilepsy at some time during their lives. One quarter of newly diagnosed cases worldwide are children. With optimal treatment, around 70% will enter remission. In the long run, antiepileptic drugs can be discontinued in almost half of affected individuals. Most patients with epilepsy undergo normal cognitive development. This relatively good prognosis contrasts with persistent public stigma surrounding the condition.

methodsselective literature review.

resultsA classification of epileptic seizures and epileptic syndromes is provided by the International League Against Epilepsy (ILAE). Epilepsies are mainly split into symptomatic forms (i.e. those with a recognizable cause) and idiopathic forms, which result from a genetic predisposition and imply no other pathology aside from epilepsy. The classification of epilepsy syndromes is based on assumed etiology, and seizure symptomatology. Drug therapy is usually started after a second unprovoked seizure. The best possible seizure control, continuation of a successful school career, and preservation of a stable family situation are equally important therapeutic aims.

Indexed as

childhood epilepsyfebrile seizuresmedical treatmentseizure intervalseizure symptoms

Identifiers

PMID19629244
PMCPMC2696870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.